DEVELOPMENT AND VALIDATION OF FIRST-EVER SPEECH-SPECIFIC PERCEPTUAL SPEECH EVALUATION TOOL FOR PATIENTS WITH HEAD AND NECK CANCER: THE LONDON SPEECH EVALUATION (LSE) SCALE

Background. The aim of this study was to develop and validate the first ever speech-specific perceptual speech-evaluation tool for patients with head and neck cancer. Methods. Five speech parameters (intelligibility, articulation, speech rate, nasality, and asthenia) and overall grade were included and evaluated. Speech samples of 117 subjects were recorded on electroglottograph equipment using a standard protocol and were independently judged and rated by 3 experienced speech and language therapists and re-rated 12 weeks apart. Results. Among patients the Cronbach's alpha (a) coefficients for internal consistency for connected speech were 0.89, whereas for single words the a coefficients ranged between 0.80 and 0.84. The Spearman's correlation coefficients for intra-rater reliability for connected speech and words varied between 0.30 and 0.90 and 0.49 and 0.76, respectively, whereas for inter-rater reliability the coefficients ranged between 0.53 and 0.99 and 0.56 and 0.99, respectively. For construct validity, the Spearman's correlation coefficient ranged between 0.41 and 0.55. Conclusions. The London Speech Evaluation (LSE) scale demonstrated a high reliability and validity in our cohort of patients with head and neck cancer. surgery. (C) 2011 Wiley Periodicals, Inc. Head Neck 34: 94-103, 2012